229 related articles for article (PubMed ID: 26658282)
1. Effect of Statin Treatment and Low-Density Lipoprotein-Cholesterol on Short-Term Mortality in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention - Multicenter Registry From Tokyo CCU Network Database.
Miura M; Yamasaki M; Uemura Y; Yoshikawa M; Miyauchi K; Tanaka H; Miyachi H; Yamashita J; Suzuki M; Yamamoto T; Nagao K; Komuro I; Takayama M
Circ J; 2016; 80(2):461-8. PubMed ID: 26658282
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention.
Oduncu V; Erkol A; Kurt M; Tanboğa IH; Karabay CY; Şengül C; Bulut M; Özveren O; Fotbolcu H; Akgün T; Türkyilmaz E; Kırma C
Int J Cardiol; 2013 Jul; 167(2):458-63. PubMed ID: 22305817
[TBL] [Abstract][Full Text] [Related]
3. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
[TBL] [Abstract][Full Text] [Related]
4. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol.
Lee KH; Jeong MH; Kim HM; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
J Am Coll Cardiol; 2011 Oct; 58(16):1664-71. PubMed ID: 21982310
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥ 50% reduction from baseline versus <70 mg/dL.
Cho KH; Jeong MH; Park KW; Kim HS; Lee SR; Chae JK; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC;
Int J Cardiol; 2015; 187():478-85. PubMed ID: 25846658
[TBL] [Abstract][Full Text] [Related]
6. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
[TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study.
Miura T; Izawa A; Motoki H; Miyashita Y; Kashima Y; Ebisawa S; Tomita T; Koyama J; Ikeda U
PLoS One; 2015; 10(6):e0127835. PubMed ID: 26083546
[TBL] [Abstract][Full Text] [Related]
8. [Early initiation of statin therapy in patients with acute myocardial infarction after successful percutaneous coronary intervention].
Katayama N; Nakao K; Horiuchi K; Ogawa H; Honda T
J Cardiol; 2004 Oct; 44(4):131-40. PubMed ID: 15532243
[TBL] [Abstract][Full Text] [Related]
9. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).
Ota T; Ishii H; Suzuki S; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Tanaka A; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539
[TBL] [Abstract][Full Text] [Related]
10. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox).
Reddy VS; Bui QT; Jacobs JR; Begelman SM; Miller DP; French WJ;
Am J Cardiol; 2015 Mar; 115(5):557-62. PubMed ID: 25727079
[TBL] [Abstract][Full Text] [Related]
12. Statin Treatment by Low-Density Lipoprotein Cholesterol Levels in Patients With Non-ST-Segment Elevation Myocardial Infarction/Unstable Angina Pectoris (from the CRUSADE Registry).
O'Brien EC; Simon DN; Roe MT; Wang TY; Peterson ED; Alexander KP
Am J Cardiol; 2015 Jun; 115(12):1655-60. PubMed ID: 25888303
[TBL] [Abstract][Full Text] [Related]
13. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox).
Cho KH; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Seung KB; Park SJ;
Am J Cardiol; 2010 Oct; 106(8):1061-8. PubMed ID: 20920639
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical impact of decreased low-density lipoprotein cholesterol level at baseline on the long-term prognosis in patients with acute coronary syndrome.
Nakahashi T; Tada H; Sakata K; Yakuta Y; Tanaka Y; Nomura A; Gamou T; Terai H; Horita Y; Ikeda M; Namura M; Takamura M; Hayashi K; Yamagishi M; Kawashiri MA
Heart Vessels; 2018 Jul; 33(7):695-705. PubMed ID: 29288404
[TBL] [Abstract][Full Text] [Related]
16. Treat-to-target lipid control is effective but highlighted poor prognosis without indication of statin following percutaneous coronary intervention.
Tanaka S; Ikari Y; Ijichi T; Nakazawa G
Cardiovasc Interv Ther; 2017 Oct; 32(4):358-364. PubMed ID: 27539447
[TBL] [Abstract][Full Text] [Related]
17. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
[TBL] [Abstract][Full Text] [Related]
18. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
[TBL] [Abstract][Full Text] [Related]
19. Threshold level of low-density lipoprotein cholesterol for the short-term benefit of statin therapy in the acute phase of myocardial infarction.
Lee JH; Park SH; Yang DH; Park HS; Cho Y; Lee WK; Jeong MH; Kim YJ; Jun JE; Chae SC;
Clin Cardiol; 2012 Apr; 35(4):211-8. PubMed ID: 22102488
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol levels and the association of statins with in-hospital mortality of myocardial infarction patients insights from a Chilean registry of myocardial infarction.
Martínez G; Rigotti A; Acevedo M; Navarrete C; Rosales J; Giugliano RP; Corbalán R
Clin Cardiol; 2013 Jun; 36(6):305-11. PubMed ID: 23494544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
